Document Detail

Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
MedLine Citation:
PMID:  20498236     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Therapy for chronic systolic heart failure (sHF) has improved over the past 2 decades, but the armamentarium of drugs is limited and consequently sHF remains a leading cause of death and disability. In this investigation, we examined the effects of a novel cardiac myosin activator, omecamtiv mecarbil (formerly CK-1827452) in 2 different models of heart failure.
METHODS AND RESULTS: Two different models of sHF were used: (1) pacing-induced sHF after myocardial infarction (MI-sHF) and (2) pacing-induced sHF after 1 year of chronic pressure overload left ventricular hypertrophy (LVH-sHF). Omecamtiv mecarbil increased systolic function in sHF dogs, chronically instrumented to measure LV pressure, wall thickness, and cardiac output. Omecamtiv mecarbil, infused for 24 hours, induced a sustained increase without desensitization (P<0.05) in wall thickening (25+/-6.2%), stroke volume (44+/-6.5%) and cardiac output (22+/-2.8%), and decreased heart rate (15+/-3.0%). The major differences between the effect of omecamtiv mecarbil on cardiac function and the effect induced by a catecholamine, for example, dobutamine, is that omecamtiv mecarbil did not increase LV dP/dt but rather increased LV systolic ejection time by 26+/-2.9% in sHF. Another key difference is that myocardial O(2) consumption (MVO(2)), which increases with catecholamines, was not significantly affected by omecamtiv mecarbil.
CONCLUSIONS: These results demonstrate that chronic infusion of the cardiac myosin activator, omecamtiv mecarbil, improves LV function in sHF without the limitations of progressive desensitization and increased MVO(2.) This unique profile may provide a new therapeutic approach for patients with sHF.
You-Tang Shen; Fady I Malik; Xin Zhao; Christophe Depre; Sunil K Dhar; Patricio Abarzúa; David J Morgans; Stephen F Vatner
Related Documents :
18490286 - The associations between tricuspid annular plane systolic excursion (tapse), ventricula...
3139326 - Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and comp...
17385306 - Changes with age in left ventricular function and volumes at rest and postexercise in p...
24957516 - Ischemic and functional mitral regurgitation in heart failure: natural history and trea...
9633076 - Alternative locations for internal defibrillator electrodes.
19536376 - The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardiu...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-24
Journal Detail:
Title:  Circulation. Heart failure     Volume:  3     ISSN:  1941-3297     ISO Abbreviation:  Circ Heart Fail     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-21     Completed Date:  2010-08-10     Revised Date:  2011-10-27    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  522-7     Citation Subset:  IM    
CV Dynamics, Inc, North Brunswick, NJ, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Cardiac Myosins / drug effects*,  metabolism
Disease Models, Animal
Dobutamine / pharmacology
Drug Administration Schedule
Heart Failure, Systolic / drug therapy*,  physiopathology
Heart Function Tests
Infusions, Intravenous
Myocardial Contraction / drug effects*
Myocardial Infarction / drug therapy,  physiopathology
Oxygen Consumption / drug effects
Random Allocation
Stroke Volume / drug effects
Treatment Outcome
Urea / analogs & derivatives,  pharmacology
Ventricular Function, Left / drug effects*
Ventricular Remodeling / drug effects
Reg. No./Substance:
0/omecamtiv mecarbil; 34368-04-2/Dobutamine; 57-13-6/Urea; EC 3.6.1.-/Cardiac Myosins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Permeant anions contribute to voltage dependence of ClC-2 chloride channel by interacting with the p...
Next Document:  Managing financial conflict of interest in biomedical research.